Is Serina Therapeutics Stock a Good Investment?
Serina Therapeutics Investment Advice | SER |
- Examine Serina Therapeutics' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Serina Therapeutics' leadership team and their track record. Good management can help Serina Therapeutics navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Serina Therapeutics' business and its evolving consumer preferences.
- Compare Serina Therapeutics' performance and market position to its competitors. Analyze how Serina Therapeutics is positioned in terms of product offerings, innovation, and market share.
- Check if Serina Therapeutics pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Serina Therapeutics' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Serina Therapeutics stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Serina Therapeutics is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Serina Therapeutics Stock
Researching Serina Therapeutics' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 58.0% of the company outstanding shares are owned by corporate insiders. The company had not issued any dividends in recent years. Serina Therapeutics had 28:1000 split on the 15th of March 2024.
To determine if Serina Therapeutics is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Serina Therapeutics' research are outlined below:
| Serina Therapeutics generated a negative expected return over the last 90 days | |
| Serina Therapeutics has high historical volatility and very poor performance | |
| Serina Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Serina Therapeutics was previously known as AgeX Therapeutics and was traded on NYSE MKT Exchange under the symbol AGE. | |
| The company reported the last year's revenue of 142 K. Reported Net Loss for the year was (14.8 M) with profit before taxes, overhead, and interest of 0. | |
| Serina Therapeutics generates negative cash flow from operations | |
| Serina Therapeutics has a frail financial position based on the latest SEC disclosures | |
| About 58.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from nypost.com: Jennifer Lopez interviewer awkwardly calls out her age Did he just say that |
Serina Therapeutics Quarterly Cost Of Revenue |
|
Serina Therapeutics' market capitalization trends
The company currently falls under 'Micro-Cap' category with a total capitalization of 57.2 M.Market Cap |
|
Serina Therapeutics' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.30) | (1.37) | |
| Return On Capital Employed | (1.65) | (1.56) | |
| Return On Assets | (1.24) | (1.30) | |
| Return On Equity | (2.71) | (2.57) |
Determining Serina Therapeutics' profitability involves analyzing its financial statements and using various financial metrics to determine if Serina Therapeutics is a good buy. For example, gross profit margin measures Serina Therapeutics' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Serina Therapeutics' profitability and make more informed investment decisions.
Basic technical analysis of Serina Stock
As of the 18th of December 2024, Serina Therapeutics has the Coefficient Of Variation of (5,360), insignificant risk adjusted performance, and Variance of 60.13. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Serina Therapeutics, as well as the relationship between them. Please validate Serina Therapeutics risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Serina Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 4.79 per share. Given that Serina Therapeutics has information ratio of (0.03), we advise you to double-check Serina Therapeutics's current market performance to make sure the company can sustain itself at a future point.Serina Therapeutics' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Serina Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Serina Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Serina Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand Serina Therapeutics' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Serina Therapeutics' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | 0.1887 | |||
| Mean Deviation | 5.17 | |||
| Coefficient Of Variation | (5,360) | |||
| Standard Deviation | 7.75 | |||
| Variance | 60.13 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.1787 | |||
| Maximum Drawdown | 44.89 | |||
| Value At Risk | (9.81) | |||
| Potential Upside | 15.42 | |||
| Skewness | 1.46 | |||
| Kurtosis | 3.78 |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | 0.1887 | |||
| Mean Deviation | 5.17 | |||
| Coefficient Of Variation | (5,360) | |||
| Standard Deviation | 7.75 | |||
| Variance | 60.13 | |||
| Information Ratio | (0.03) | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.77) | |||
| Treynor Ratio | 0.1787 | |||
| Maximum Drawdown | 44.89 | |||
| Value At Risk | (9.81) | |||
| Potential Upside | 15.42 | |||
| Skewness | 1.46 | |||
| Kurtosis | 3.78 |
Consider Serina Therapeutics' intraday indicators
Serina Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Serina Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 5588.38 | |||
| Daily Balance Of Power | 0.9412 | |||
| Rate Of Daily Change | 1.15 | |||
| Day Median Price | 4.66 | |||
| Day Typical Price | 4.7 | |||
| Price Action Indicator | 0.45 | |||
| Period Momentum Indicator | 0.64 |
Serina Stock media impact
Far too much social signal, news, headlines, and media speculation about Serina Therapeutics that are available to investors today. That information is available publicly through Serina media outlets and privately through word of mouth or via Serina internal channels. However, regardless of the origin, that massive amount of Serina data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Serina Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Serina Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Serina Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Serina Therapeutics alpha.
Serina Therapeutics Corporate Executives
Elected by the shareholders, the Serina Therapeutics' board of directors comprises two types of representatives: Serina Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Serina. The board's role is to monitor Serina Therapeutics' management team and ensure that shareholders' interests are well served. Serina Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Serina Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Bentley | Chief CoFounder | Profile | |
| Milton Harris | CoFounder Board | Profile |
Additional Tools for Serina Stock Analysis
When running Serina Therapeutics' price analysis, check to measure Serina Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Serina Therapeutics is operating at the current time. Most of Serina Therapeutics' value examination focuses on studying past and present price action to predict the probability of Serina Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Serina Therapeutics' price. Additionally, you may evaluate how the addition of Serina Therapeutics to your portfolios can decrease your overall portfolio volatility.